There are 413 resources available
Clinical implementation of oral SERD: Present and future
Presenter: Carmen Criscitiello
Session: Novel endocrine therapies
Resources:
Slides
Webcast
Biological peculiarities and clinical utility of genomic testing
Presenter: Ann Partridge
Session: Special considerations in young breast cancer patients
Resources:
Slides
Webcast
PROTAC: Challenges and opportunity in breast cancer
Presenter: Erika Hamilton
Session: Novel endocrine therapies
Resources:
Slides
Webcast
Real-world data: Towards achieving the achievable in cancer care
Presenter: Josee-Lyne Ethier
Session: Utility of real-world data
Resources:
Slides
Webcast
Which checkpoint inhibitor, in which biomarker sub-group and when: What is approved, what is coming and what are the trials telling us
Presenter: Sibylle Loibl
Session: New comers in the early breast cancer setting: Checkpoint and PARP inhibitors
Resources:
Slides
Webcast
Optimizing adjuvant endocrine therapy
Presenter: Alexandru Eniu
Session: Special considerations in young breast cancer patients
Resources:
Slides
Webcast
CERAN, SERCA: What to expect in the coming years
Presenter: Philippe Aftimos
Session: Novel endocrine therapies
Resources:
Slides
Webcast
Quality, cost and survival: Can real-world data help to solve the equation?
Presenter: Marina Borges
Session: Utility of real-world data
Resources:
Slides
Webcast
How to improve outcomes in those non-pCR after NACT+CPI
Presenter: Sheeba Irshad
Session: New comers in the early breast cancer setting: Checkpoint and PARP inhibitors
Resources:
Slides
Webcast
Clinical implications of germline testing: BRCA and beyond
Presenter: Shani Paluch-Shimon
Session: Special considerations in young breast cancer patients
Resources:
Slides
Webcast